Medication management of type 2 diabetes in residential aged care

Jacquelina Stasinopoulos, J Simon Bell, Jo Anne Manski-Nankervis, Michelle E Hogan, Peter Jenkin, Janet K Sluggett

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Background
Medication management of type 2 diabetes mellitus (T2DM) in residential aged care facilities (RACFs) requires consideration of the residents’ goals of care and susceptibility to adverse drug events (ADEs).

Objective
The aim of this article is to review best practice medication management for residents diagnosed with T2DM.

Discussion
Management of T2DM in RACFs is often focused on maintaining residents’ quality of life rather than intensive glycaemic management to reduce chronic complications, because the risks of intensive glycaemic management typically outweigh the potential benefits. Australian RACF guidelines recommend individualised glycated haemoglobin targets of 7–8.5% (53–69 mmol/mol). Strategies to reduce the risk of preventable ADEs may include education for residents, carers and staff; assessment of hypoglycaemic risk and renal function; medication review and regimen simplification; de-intensification of glucose-lowering medications; and appropriate end-of-life medication management. Use of a resident-centred multidisciplinary approach and resources tailored to the RACF setting will support residents to achieve best possible health outcomes and quality of life.
Original languageEnglish
Pages (from-to)675-681
Number of pages7
JournalAustralian Journal of General Practice
Volume47
Issue number10
DOIs
Publication statusPublished - Oct 2018

Keywords

  • diabetes
  • long-term care
  • residential aged care
  • Australia
  • Medication use
  • medication management

Cite this

Stasinopoulos, Jacquelina ; Bell, J Simon ; Manski-Nankervis, Jo Anne ; Hogan, Michelle E ; Jenkin, Peter ; Sluggett, Janet K. / Medication management of type 2 diabetes in residential aged care. In: Australian Journal of General Practice. 2018 ; Vol. 47, No. 10. pp. 675-681.
@article{bcaf44f83a804b8e971d63bd2206ebab,
title = "Medication management of type 2 diabetes in residential aged care",
abstract = "BackgroundMedication management of type 2 diabetes mellitus (T2DM) in residential aged care facilities (RACFs) requires consideration of the residents’ goals of care and susceptibility to adverse drug events (ADEs). ObjectiveThe aim of this article is to review best practice medication management for residents diagnosed with T2DM.DiscussionManagement of T2DM in RACFs is often focused on maintaining residents’ quality of life rather than intensive glycaemic management to reduce chronic complications, because the risks of intensive glycaemic management typically outweigh the potential benefits. Australian RACF guidelines recommend individualised glycated haemoglobin targets of 7–8.5{\%} (53–69 mmol/mol). Strategies to reduce the risk of preventable ADEs may include education for residents, carers and staff; assessment of hypoglycaemic risk and renal function; medication review and regimen simplification; de-intensification of glucose-lowering medications; and appropriate end-of-life medication management. Use of a resident-centred multidisciplinary approach and resources tailored to the RACF setting will support residents to achieve best possible health outcomes and quality of life.",
keywords = "diabetes, long-term care, residential aged care, Australia, Medication use, medication management",
author = "Jacquelina Stasinopoulos and Bell, {J Simon} and Manski-Nankervis, {Jo Anne} and Hogan, {Michelle E} and Peter Jenkin and Sluggett, {Janet K}",
year = "2018",
month = "10",
doi = "10.31128/AJGP-05-18-4582",
language = "English",
volume = "47",
pages = "675--681",
journal = "Australian Journal of General Practice",
issn = "2208-7958",
publisher = "The Royal Australian College of General Practitioners",
number = "10",

}

Medication management of type 2 diabetes in residential aged care. / Stasinopoulos, Jacquelina; Bell, J Simon; Manski-Nankervis, Jo Anne; Hogan, Michelle E; Jenkin, Peter; Sluggett, Janet K.

In: Australian Journal of General Practice, Vol. 47, No. 10, 10.2018, p. 675-681.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Medication management of type 2 diabetes in residential aged care

AU - Stasinopoulos, Jacquelina

AU - Bell, J Simon

AU - Manski-Nankervis, Jo Anne

AU - Hogan, Michelle E

AU - Jenkin, Peter

AU - Sluggett, Janet K

PY - 2018/10

Y1 - 2018/10

N2 - BackgroundMedication management of type 2 diabetes mellitus (T2DM) in residential aged care facilities (RACFs) requires consideration of the residents’ goals of care and susceptibility to adverse drug events (ADEs). ObjectiveThe aim of this article is to review best practice medication management for residents diagnosed with T2DM.DiscussionManagement of T2DM in RACFs is often focused on maintaining residents’ quality of life rather than intensive glycaemic management to reduce chronic complications, because the risks of intensive glycaemic management typically outweigh the potential benefits. Australian RACF guidelines recommend individualised glycated haemoglobin targets of 7–8.5% (53–69 mmol/mol). Strategies to reduce the risk of preventable ADEs may include education for residents, carers and staff; assessment of hypoglycaemic risk and renal function; medication review and regimen simplification; de-intensification of glucose-lowering medications; and appropriate end-of-life medication management. Use of a resident-centred multidisciplinary approach and resources tailored to the RACF setting will support residents to achieve best possible health outcomes and quality of life.

AB - BackgroundMedication management of type 2 diabetes mellitus (T2DM) in residential aged care facilities (RACFs) requires consideration of the residents’ goals of care and susceptibility to adverse drug events (ADEs). ObjectiveThe aim of this article is to review best practice medication management for residents diagnosed with T2DM.DiscussionManagement of T2DM in RACFs is often focused on maintaining residents’ quality of life rather than intensive glycaemic management to reduce chronic complications, because the risks of intensive glycaemic management typically outweigh the potential benefits. Australian RACF guidelines recommend individualised glycated haemoglobin targets of 7–8.5% (53–69 mmol/mol). Strategies to reduce the risk of preventable ADEs may include education for residents, carers and staff; assessment of hypoglycaemic risk and renal function; medication review and regimen simplification; de-intensification of glucose-lowering medications; and appropriate end-of-life medication management. Use of a resident-centred multidisciplinary approach and resources tailored to the RACF setting will support residents to achieve best possible health outcomes and quality of life.

KW - diabetes

KW - long-term care

KW - residential aged care

KW - Australia

KW - Medication use

KW - medication management

U2 - 10.31128/AJGP-05-18-4582

DO - 10.31128/AJGP-05-18-4582

M3 - Review Article

VL - 47

SP - 675

EP - 681

JO - Australian Journal of General Practice

JF - Australian Journal of General Practice

SN - 2208-7958

IS - 10

ER -